Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-27 15:19:47 - browse：6192

The corporate offices of Massachusetts General Brigham hospitals in Assembly Square in Somerville. Lane Turner/Globe Staff

The severing of ties between two of Boston’s biggest health care giants has placed one of the nation’s largest health care systems in the position of figuring out how, exactly, to fill a new hole in its oncology services, at a time when cancer care is changing rapidly.

Earlier this month, Dana-Farber Cancer Institute surprised the medical community and even its partner, Brigham and Women’s Hospital, when it announced that it would end their nearly 30-year collaboration. The split will take a few years to play out — Dana-Farber and Brigham and Women’s have a contract into 2028 — but has shaken patients and physicians.

Anne Klibanski, chief executive of Brigham and Women’s parent organization, Mass General Brigham, placed the blame on Dana-Farber executives. The two parties had been in discussions about extending their contract for months when the split was announced. “The decision was made by the Farber. It was announced. Now, we just have to plan forward,” she said. Klibanski shared her views on the split at a meeting with Boston Globe opinion editors on Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Life sciences investors close nearly $6 billion in new funds

entertainment

WSS

Coloradans with cystic fibrosis could lose access to Trikafta

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Kidney transplant patients stopped immunosuppressants in trial

Life sciences investors close nearly $6 billion in new funds

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

focus

Wikipedia

focus

Anesthesiologist group: stop taking Ozempic before surgery

How neuroscience research could help beat back brain cancer

Drug repurposing or repositioning? The language matters

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Trump demands the U.S. pay no more for drugs than other countries … again

Key Senate panel to consider PBM, drug pricing reform package

DIEP, the 'gold standard' of breast reconstruction, is under threat

Travis Kelce and the trap of celebrity vaccine endorsements

Wildfire smoke exposes gaps in outdoor worker protections

DeepMind touts AlphaFold's new skills as protein folding AI models face off

focus

Coloradans with cystic fibrosis could lose access to Trikafta

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Travis Kelce and the trap of celebrity vaccine endorsements

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

How neuroscience research could help beat back brain cancer

Live blog: Hearing on CRISPR

entertainment

entertainment

hotspot

leisure time